[HTML][HTML] Cancer immunotherapy by blocking immune checkpoints on innate lymphocytes
… successful cancer immunotherapy strategies … innate lymphocytes by ICI in both solid tumors
and hematological malignancies. Overall, we believe that, in our near future, immunotherapy …
and hematological malignancies. Overall, we believe that, in our near future, immunotherapy …
Targeting innate immune pathways for cancer immunotherapy
LL Cao, JC Kagan - Immunity, 2023 - cell.com
… The innate immune system is critical for inducing durable and protective T cell responses to
… for cancer immunotherapy. In this review, we present a framework wherein distinct innate …
… for cancer immunotherapy. In this review, we present a framework wherein distinct innate …
[HTML][HTML] Engineering the bridge between innate and adaptive immunity for cancer immunotherapy: focus on γδ T and NK cells
F Morandi, M Yazdanifar, C Cocco, A Bertaina, I Airoldi - Cells, 2020 - mdpi.com
… The use of iNKT TCR in cancer immunotherapy has shown … a bi-potential innate lymphocyte
can be exploited for treating … NK cells are bone marrow-derived innate lymphocytes capable …
can be exploited for treating … NK cells are bone marrow-derived innate lymphocytes capable …
Innate lymphoid cells and cancer
… Despite the unprecedented success of this first wave of cancer immunotherapies based
on immune checkpoint inhibitors and CAR T cells, many people fail to benefit from such …
on immune checkpoint inhibitors and CAR T cells, many people fail to benefit from such …
Chimeric antigen receptor-and natural killer cell receptor-engineered innate killer cells in cancer immunotherapy
C Zhang, Y Hu, W Xiao, Z Tian - Cellular & Molecular Immunology, 2021 - nature.com
… CAR- and NKR-engineered innate killer cells for use in cancer immunotherapy Innate
lymphocytes constitute a heterogeneous group of cells that includes innate lymphoid cells (ILCs, …
lymphocytes constitute a heterogeneous group of cells that includes innate lymphoid cells (ILCs, …
Harnessing innate immunity using biomaterials for cancer immunotherapy
… of innate immune system to enhance cancer immunotherapy. We highlight the design principles
of various biomaterials used for innate … -based cancer immunotherapy for clinical trials/…
of various biomaterials used for innate … -based cancer immunotherapy for clinical trials/…
[HTML][HTML] Targeting innate immunity in cancer therapy
… The majority of current cancer immunotherapy strategies target and potentiate antitumor
adaptive immune responses. Unfortunately, the efficacy of these treatments has been limited to …
adaptive immune responses. Unfortunately, the efficacy of these treatments has been limited to …
Targeting the innate immune system with nanoparticles for cancer immunotherapy
K Li, Z Zhang, Y Mei, M Li, Q Yang, Q Wu… - Journal of Materials …, 2022 - pubs.rsc.org
… cancer immunotherapy, the recent studies presented in this review prove that
nanoparticle-incorporated cancer immunotherapy is a highly promising treatment for cancer patients. …
nanoparticle-incorporated cancer immunotherapy is a highly promising treatment for cancer patients. …
[HTML][HTML] Innate lymphocytes: pathogenesis and therapeutic targets of liver diseases and cancer
Y Chen, Z Tian - Cellular & molecular immunology, 2021 - nature.com
… innate lymphocytes with tissue residency has gradually become the focus of research. In this
review, we address the current knowledge regarding hepatic innate lymphocytes … cancer. A …
review, we address the current knowledge regarding hepatic innate lymphocytes … cancer. A …
[HTML][HTML] Innate immune cells and their contribution to T-cell-based immunotherapy
P Ginefra, G Lorusso, N Vannini - International journal of molecular …, 2020 - mdpi.com
… innate immune cells in the context of cancer immunotherapy. In this review, we describe the
contribution of innate immune cells in T-cell-based cancer immunotherapy … cancer patients. …
contribution of innate immune cells in T-cell-based cancer immunotherapy … cancer patients. …
相关搜索
- immune checkpoints cancer immunotherapy
- cells in cancer immunotherapy
- chimeric antigen receptor cancer immunotherapy
- enhanced cancer immunotherapy
- liver diseases and cancer innate lymphocytes
- challenges in cancer immunotherapy
- tumor immunology cancer immunotherapy
- promising frontier cancer immunotherapy
- advances in cancer immunotherapy
- great potential cancer immunotherapy
- genetic engineering cancer immunotherapy
- tailoring biomaterials cancer immunotherapy
- old paradigms cancer immunotherapy
- role of cd4 cancer immunotherapy
- engineered natural killer cancer immunotherapy
- car nk cancer immunotherapy